Cardiology · 2 h ago
HFSA Statement Recommends Recognizing Right Heart Failure as a Distinct Syndrome
A Heart Failure Society of America scientific statement argues that right heart failure should be recognized as a distinct clinical syndrome, not only as a consequence of left-sided disease. It presents a framework for evaluation and management across several clinical settings; the source does not report original patient data.
- Calls for RHF to be treated as a distinct syndrome
- Covers acute ICU care and several RHF settings
- Summarizes existing evidence; no original patient data reported
A new Heart Failure Society of America (HFSA) scientific statement, published in the Journal of Cardiac Failure, synthesizes current evidence on right heart failure (RHF). It calls for RHF to be treated as a distinct clinical syndrome and outlines a structured approach to recognition, evaluation and management across cardiovascular disease settings.
The statement describes a three-pillar approach to acute RHF in the intensive care unit, risk-assessment tools for escalation of pulmonary arterial hypertension therapy, and guidance on the use of PAH-targeted therapies, mechanical circulatory support and tricuspid valve interventions. It addresses RHF in cardiogenic shock, PAH, chronic left heart failure, and after mechanical circulatory support or transplantation. No original study population or quantitative outcomes are reported in the release.
The statement aims to support earlier recognition and more consistent, physiology-driven care, while identifying research gaps. Its recommendations are based on a synthesis of existing evidence; the release does not provide enough detail to assess specific recommendations or their supporting evidence. The statement and an accompanying take-home messages slide deck are available through HFSA.
In practice
The HFSA statement frames right heart failure as a distinct syndrome and offers clinicians a structured approach across cardiogenic shock, pulmonary arterial hypertension, chronic left heart failure, and post-transplant or mechanical-support settings. It also addresses escalation of PAH therapy and use of mechanical support and tricuspid interventions. This is a synthesis of current evidence, not a trial, and the release does not provide the detailed recommendations or evidence grading needed to determine how specific treatment decisions should change.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
PR Newswire – Health: New HFSA Scientific Statement Calls for Right Heart Failure to Be Recognized as a Distinct Clinical Syndrome ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.